Arbios Technologies Inc. is an early-stage company organized to develop, manufacture and market liver assist devices to meet the urgent need for therapy that facilitates recovery from liver failure. In Oct. 2002 Arbios Technologies Inc. was acquired by Shiprock Inc. (OTCBB: SRKI) After the merger, Shiprock changed its name to "Arbios Systems Inc." and continues to trade on the OTC Bulletin Board under a new trading symbol. The company's products in development are selective plasma exchange therapy (SEPET), which is a blood purification therapy device for patients with liver failure and LIVERAID, which is a bioartificial liver. The SEPET cartridge is designed to remove toxins in the patient's blood, while the LIVERAID cartridge, which contains sterile pig liver cells, is designed to artificially provide liver functions. A
